- Open Access
Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health
© Bendixen et al.; licensee BioMed Central Ltd. 2012
- Received: 26 September 2011
- Accepted: 30 April 2012
- Published: 30 April 2012
Duchenne muscular dystrophy (DMD) is characterized by muscle damage and progressive loss of muscle function in male children. DMD is one of the most devastating genetically linked neuromuscular diseases for which there is currently no cure. Most clinical studies for DMD utilize a standard protocol for measurement exploring pathophysiology, muscle strength and timed tasks. However, we propose that examining broader components of health as emphasized by the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY) may be of great value to children and their families, and important outcomes for future clinical trials.
Fifty boys with DMD and 25 unaffected age-matched boys completed two self-report measures: the Children’s Assessment of Participation and Enjoyment and the Pediatric Quality of Life InventoryTM 4.0. We investigated differences between the two groups with regard to participation in life activities and perceived quality of life (QoL). Additionally, we compared participation in activities and QoL in both cohorts of younger and older boys.
Participation in physical activities was significantly lower in boys with DMD than unaffected boys. Perceived QoL was markedly diminished in children with DMD relative to unaffected controls, except in the emotional domain. The amount of time boys engage in an activity, as well as participation in social activities, declined for our older boys with DMD but no changes were observed for our older unaffected boys. For both groups, QoL remained constant over time.
The ICF-CY provides a conceptual framework and specific terminology that facilitates investigation of the consequences of impairment in children and youth. Our study is one of the first to explore participation in a cohort of boys with DMD. It was not surprising that activities of choice for boys with DMD were less physical in nature than unaffected boys their age, but the consequences of less social engagement as the boys with DMD age is of great concern. Results from our study underscore the need to further evaluate activities that children elect to participate in, with special emphasis on facilitators and barriers to participation and how participation changes throughout the course of a disease.
- Duchenne muscular dystrophy
- Quality of life
Duchenne muscular dystrophy (DMD), the most common form of muscular dystrophy, is a genetically-linked disease of male children which affects one in 3,300 boys . The muscle damage and weakness which occurs with this disease leads to a progressive decline in the boy’s ability to perform everyday tasks, such as climbing stairs and walking short distances [2–4]. Disruption to the lives of children with DMD and their families begins as early as age three when muscle weakness interferes with daily activities. As the weakness progresses, the boys often become confined to wheelchairs early in the second decade of life . End stage cardiac and respiratory complications lead to death which frequently occurs around the age of 20 [6–8]. Overall, DMD leads to a loss of functional independence and deterioration in the quality of life for both the children and their families [9–13].
It is imperative to develop techniques which can be used to follow the progression of this disease as well as the efficacy of any therapeutic interventions. Traditional measures used to follow DMD are typically clinical measures of skeletal muscle structure and function [14–17]. These outcome measures include muscle strength, manual muscle testing, range of motion, forced vital capacity, anthropometric tests, timed functional tests and the 6 min walk. In addition, there are also invasive techniques, such as muscle biopsy, and noninvasive techniques, such as magnetic resonance imaging, which have been used to follow the structural and compositional changes that occur with the progression of DMD [18, 19]. Although these measures represent the current models on which clinical progression of the disease is based [20, 21], such measurements may not fully capture the impact of the disease on real life activities. The medical community has long assumed that disability directly correlates with the measurements made in a clinical setting. However, it has been shown that measures of pathophysiology and motor function assessed in the clinic do not necessarily relate to or predict how patients deal with life situations [22–24]. Clinical measures are often disconnected from the context and synergy of everyday life. Therefore, perhaps other nontraditional outcome measures would also be valuable in following the progression of DMD.
Quality of life (QoL) measures have often been used in the healthcare field to compare diseases, determine the effects of an illness , and measure the outcomes of treatments and clinical trials [32, 33]. It is possible that QoL measures can shed new insight into patient outcomes that traditional physical measures may not be able to assess [11, 33–35]. It has been reported that children with chronic illnesses typically score below healthy children in QoL assessments, although patients with progressive diseases such as DMD have been excluded from most comparative studies [36, 37]. Surprisingly, there is little information on the QoL of children with DMD despite parents reporting quality of life issues as an important challenge for their children [38, 39]. The progressive decline in strength and loss of the ability to participate in activities with their peers can lead to social exclusion and isolation for these boys. These factors may have a significant impact on how boys with DMD perceive their quality of life.
The objectives of this investigation were 1) to compare boys with DMD with an unaffected age-matched population of boys with regard to participation in real life activities and perceived quality of life, 2) to determine the differences in participation in activities and perceived quality of life in younger and older boys with DMD and unaffected boys to explore the effects of disease progression, and 3) to determine if there is a relationship between participation in activities and perceived quality of life in younger and older boys with DMD and unaffected boys. This was accomplished by using two self-report outcome measures, the Children’s Assessment of Participation and Enjoyment (CAPE) and the Pediatric Quality of Life InventoryTM 4.0 (PedsQL).
In our study we collected data from a cohort of boys participating in a larger natural history study exploring biomarkers of disease progression in Duchenne muscular dystrophy. Our study investigated self-report of participation levels and QoL in boys with DMD compared to unaffected age-matched boys. Fifty boys with DMD (validated through medical report using molecular genetic testing and/or immunohistochemical staining from muscle biopsy) and their parent(s) volunteered to enroll in this study. Twenty-five unaffected age-matched boys were recruited from the general population for comparisons in participation and QoL. Unaffected boys were relatively sedentary, in that they did not participate in sport specific training more than 2 times per week. All boys and their parents participated in person at our site. The boys ranged in age from 5 to 15 years. Three boys with DMD who were nonambulatory were included in this study; all others were ambulatory at the time of testing. The study was approved by the University of Florida Institutional Review Board (IRB 129-2008). Written, informed consent was obtained from the parent(s), and written assent was obtained from each participant. Following informed consent, the boys completed two paper/pencil self-report assessments which focused on participation in physical, recreational and social activities and perceived quality of life. Assessments of participation were completed with the assistance of their parent(s).
Participation was measured by the Children’s Assessment of Participation and Enjoyment (CAPE). The CAPE is designed to examine how children and youth participate in everyday activities. Scores on the CAPE are divided into five dimensions: 1) Diversity, the number of activities performed overall; 2) Intensity, the frequency of performing the activity; 3) With Whom the activity is performed; 4) Where the activity is performed; and 5) how much Enjoyment the child gets from the activity. Additionally, activities are divided into the following domains: physical, recreational, social, skill-based, and self-improvement. Three activity domains of the CAPE were used in our calculations (physical, recreational and social activities). Physical activities included such items as playing team sports, bicycling, and actively using playground equipment. Recreational activities included reading, playing cards or playing video/computer games. Social activities included visiting friends, going to the movies, and cooking. Reliability and validity of the CAPE were established using data from a longitudinal study involving 427 children with physical disabilities . Although validation studies with the CAPE did not include children with progressive diseases, such as DMD, other diagnoses which result in muscle weakness and motor difficulties were included (i.e., cerebral palsy, amputation, muscular disorders, neuropathy, orthopaedic conditions, vascular brain disorders). In addition, the CAPE was designed to be a direct measure of participation as reflected by the WHO’s ICF model . The CAPE documents what a child does in their everyday life, not the child’s competence or the degree of support required to participate in the activity . Therefore it was felt the CAPE measure would adequately capture the boys with DMD involvement in life situations.
Quality of Life (QoL) was assessed through the Pediatric Quality of Life Inventory TM 4.0 (PedsQL), which is designed to measure the core dimensions of health as delineated by the WHO (physical, emotional, social), as well as school functioning, and has been determined to be a thorough and reliable measure of QoL in children [36, 37, 41]. Generic quality of life instruments have frequently been used as patient reported outcome measures, and their use encouraged to explore the clinical meaningfulness of a change in more traditional clinical measures of body systems and overall function [26, 33]. Generic QoL measurements provide valuable information for comparing populations, but may not be sensitive enough to detect change necessary for a treatment based clinical trial . The PedsQLTM 4.0 has previously been used to evaluate patient-perceived well being in boys with DMD and unaffected controls  and to investigate agreement between boys with DMD and their parents when reporting quality of life [13, 44]. The data for the Generic Core Scales were derived from the PedsQLTM 4.0 field test . Generic Core Scales included children who are healthy, acutely ill, and chronically ill.
All statistical analyses were performed using statistical software PASW version 18.0 for Windows (PASW Inc., Chicago, IL). The Mann–Whitney U-test was used for group comparisons and the Spearman’s rank correlation coefficient test was used for non-parametric analysis of correlations. A p-value of less than or equal to 0.05 was considered statistically significant. In our aim of exploring the differences in participation in life activities and perceived QoL between younger and older unaffected boys and boys with DMD, a p-value of less than or equal to 0.01 was considered statistically significant due to the multiple number of analyses performed.
Characteristics of boys with DMD and unaffected age-matched boys
Characteristics of DMD and unaffected age-matched subjects
DMD (n = 50)
Unaffected (n = 25)
Participation and QoL in boys with DMD Vs unaffected boys
Participation and QoL in younger and older boys
Baseline CAPE and PedsQL TM responses by DMD and unaffected based on age groups: differences within and between groups
DMD (n = 50)
Unaffected (n = 25)
P value Between Groups
≥ 10 years
<10 years (n = 27)
≥ 10 years (n = 23)
<10 years (n = 13)
≥ 10 years (n = 12)
PedsQL Total Composite
Differences between the younger boys with DMD and the younger unaffected boys were observed in the CAPE area of physical participation, as well as the PedsQLTM physical subscale and total composite score (all significant at p ≤ 0.000). For our older cohort (≥10 years), boys with DMD scored significantly lower in the physical and social domains of the CAPE, as well as the PedsQLTM physical and social subscales and the total composite score (Table 2).
Relationship between participation and QoL
As the results above demonstrate, participation in activities that were social in nature declined for the older cohort of boys with DMD; self-report of QoL did not differ between the two DMD or unaffected age groups. Correlational analyses showed no significant relationship between overall participation and perceived QoL in either age group of boys with DMD or unaffected boys.
In this study we compared participation in life activities and perceived QoL between boys with DMD and an age-matched population of unaffected boys. The results showed that participation in physical activities was significantly lower in boys with DMD than unaffected controls, although other participation measures were much the same as healthy boys. Furthermore, perceived QoL was markedly diminished in children with DMD relative to unaffected controls. Another objective of this study was to compare younger boys to older boys in both the DMD and unaffected cohorts to explore both within group and between group differences in participation and QoL. For within group differences, we found that the amount of time boys with DMD engage in an activity (frequency), as well as participation in social activities, declined for our older cohort but there was no decline in participation observed for our older unaffected boys. No differences in perceived QoL were observed between the younger and older boys with DMD or the unaffected boys. Significant between age group differences were observed among the boys with DMD and the unaffected controls. Comparisons between our younger boys with DMD and our younger unaffected boys showed lower scores in diversity of activities they participate in, as well as participation in physical activities. Quality of life scores were lower in the physical subscale as well as the overall total composite score. For our older boys with DMD, lower scores were reported in both physical and social participation, as well as quality of life subscales of physical, social and total composite scores compared to our older unaffected boys. No differences were observed in the PedsQLTM subscales of emotional or school related QoL for our older boys. Finally, no correlations were observed between reports of participation and QoL in these two groups.
Our study is one of the first to explore self-report of participation in activities in a population of boys with DMD. The results demonstrated that, overall, the boys with DMD chose diverse activities in which to participate and that they were involved in their chosen activities as frequently as healthy boys. However, the activities of choice for boys with DMD were less physical in nature than unaffected boys their age. It certainly comes as no surprise that children with muscular weakness are less likely to participate in physical activities, especially as they age [46, 47]. Interestingly, physical activity for healthy boys has been reported to decline during later childhood or adolescence stages [48, 49], although we did not observe a decline in our unaffected group of boys. In contrast, this age-related decline in physical activities for unaffected boys does not appear to be due to the bodily demands of the activity [49, 50]. Moreover, physical activity participation is typically high for younger unaffected boys , but was significantly lower in our younger boys with DMD.
In boys with DMD, participation in social activities, such as visiting friends, going to parties or going to the movies was significantly lower after the age of 10 years. This is often the age when boys with DMD experience a decrease in motor abilities, such as ambulation [5, 46] and may, therefore, have less opportunity for community-based social engagement. It’s important to note the connection between physical abilities and social engagement. Poor motor skills have been associated with peer relationship difficulties, lower peer regard and greater likelihood of suffering from withdrawal . Actively engaging in physical activities, such as team sports or playing with others on the playground, helps children form peer relationships and experience a sense of self-worth and belonging to a group [30, 40, 51, 52]. Unfortunately, little is known about the social engagement of children with DMD. Although parents more often report prolonging ambulation as the most important factor in dealing with DMD [39, 53], the resulting emotional challenges of DMD and the increasing social needs of boys as they age is also of great concern [39, 54].
Our study also used self-report measures to determine the perceived QoL of the boys with DMD relative to unaffected controls. The boys with DMD reported lower physical, social and school-related scores, resulting in significantly lower total composite QoL scores. However, there was no effect of the disease in the emotional area of QoL, even as the boys aged. The differences in these responses may be due to the types of questions used in the PedsQLTM assessment. The questions addressed in the physical, social, and school-related areas are based on difficulties in actual performance, such as physical activities, making friends, or missing school due to medical/physician appointments. On the other hand, the emotional subscale of the PedsQLTM consists of questions about feelings of sadness, anger, and fear. These may be emotions that are evident in most children to some degree and may not necessarily be exaggerated by the disease. It is interesting to note that although QoL scores for boys with DMD were significantly lower than for unaffected boys, these scores did not notably decrease within the cohort of children with DMD when the disease has typically progressed. Other researchers have also reported no changes in QoL related to disease progression [11, 12, 43, 55]. In a longitudinal study, Simon and colleagues (2010) used the Life Satisfaction Index for Adolescents, which they determined to be a more effective instrument for boys with DMD based on its limited focus on physical abilities. No comparisons were made with unaffected boys, but the cohort of 95 boys with DMD did not show a significant decrease and no loss of QoL was observed among the boys most affected by the progression of the disease . Abresch et al. [56, 57] determined that physical functioning and level of disability alone did not alter overall QoL, a finding that was also reported by Kohler et al.  using the Short-Form 36 of the medical outcome questionnaire. Finally, based on PedsQLTM scores established and validated in a variety of patient populations [37, 58], the overall scores for our cohort of boys with DMD were lower than scores from children with other major chronic health issues.
In our study, we did not find a relationship between CAPE participation scores and PedsQLTM quality of life scores for unaffected boys or boys with DMD, although relationships between QoL and specific clinical measures that are typically assessed in boys with DMD have been observed. Bray et al.  found relationships between age, steroid use, physical functioning and QoL in DMD. McDonald et al.  utilized parent-proxy report and found direct relationships between the physical domains of QoL, age, and such clinical assessments as supine to stand, walk/run 10 meters and walk up 4 stairs. Findings from other studies in DMD support the thought that meaningful and developmentally important life activities, such as playing with and actively engaging with friends, may be related to QoL [11, 59]. It is difficult to explain these varying results and why we did not find a correlation between participation and QoL. Although our sample size was small, it would also appear that QoL is complex and more global in nature than the straightforward and explicit report of actual participation. As Colver theorized, QoL cannot be measured directly, but only captured through a variety of questions that seek to place value on a particular variable . Therefore, QoL is a concept and is subjective , while participation is a real life experience and is objective [61–63]. Finally, our results may differ from some studies because we chose to use child report in lieu of parent proxy report to obtain a full understanding of the children’s perception of their QoL. Literature in this area shows that parents and children often differ in their agreement of the child’s QoL [13, 44, 64], but the larger issue appears to be whether a child is capable of self-report [65, 66]. We took the stance, as others have, that children can provide valuable information about their health and that quality of life is subjective and therefore should be a person’s individual view [33, 61, 65, 66].
We acknowledge there are a few limitations to our study. Although our population of boys with DMD is rare, our sample size may be considered relatively small, especially when broken into age groups. Moreover, as this was not a longitudinal study, comparing different age groups may not be giving us information about changes as the disease progresses. Lastly, although the PedsQLTM is a thoroughly developed generic measure that is brief, easy to understand, and captures information relevant to both children with a disease/illness and unaffected children, we acknowledge that the PedsQLTM domains are limited, are not designed to assess a full range of functioning and are not specific to children with a neuromuscular disorder.
Although a progressive disease, such as DMD, influences the physical ability to participate in many activities, it’s important to acknowledge that restrictions in participation should not inevitably arise from this or any childhood disease. Optimum management of DMD requires a multidisciplinary approach that focuses on anticipatory and preventive measures as well as active interventions to address the primary and secondary complications resulting from the disorder . Such a multidisciplinary approach would benefit from using a framework to conceptualize the process of living with a progressive disease. The ICF-CY  provides a conceptual framework and specific terminology that facilitates investigation of the consequences of chronic illness and impairment in children and youth. The ICF model provides areas of intervention that can enhance the participation of children whose functional well-being is at risk. Interventions that focus on multiple aspects of the child and address participation afford children the opportunity to continue to engage in age and developmentally appropriate activities, and ultimately may serve to promote overall health [61, 62]. Results from our study underscore the need to further evaluate activities that children elect to participate in to obtain an accurate account of a child’s level of participation and how participation changes throughout the course of a disease. Additionally, exploring how participation may relate to specific clinical tests may give us a better understanding of areas of intervention.
The authors would like to like to thank the children and families who gave their time to participate in this study. We would also like to acknowledge Dr. Phil Miles for his efforts in drafting and revising the manuscript. Dr. Bendixen is currently funded through an NIH – NICHD K01mentored career development grant (5K01HD064778) and is in Phase II of an NIH K12 institutional grant (K12 HD055929). Additional funding for recruitment and participant support was provided through Parent Project Muscular Dystrophy and the Muscular Dystrophy Association (PI, K. Vandenborne) and a grant through a Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (PI, L. Sweeney).
- Deconinck N, Dan B: Pathophysiology of Duchenne muscular dystrophy. Pediatr Neurol 2007, 36(1):1–7. 10.1016/j.pediatrneurol.2006.09.016View ArticleGoogle Scholar
- Hoffman EP, Brown RH, Kunkel LM: Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51: 919–928. 10.1016/0092-8674(87)90579-4View ArticleGoogle Scholar
- Sussman M: Duchenne muscular dystrophy. J Ame Acad Orthop Surg 2002, 10(2):138–151.Google Scholar
- Tidball JG, Wehling-Henricks M: The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 2007, 102(4):1677–1686.View ArticleGoogle Scholar
- Emery A, Muntoni F: Duchenne Muscular Dystrophy. 3rd edition. Oxford University Press, Oxford; 2003.Google Scholar
- Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C: Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary care. Lancet Neurol 2010, 9(2):177–189. 10.1016/S1474-4422(09)70272-8View ArticleGoogle Scholar
- Darras BT, Menache CC, Kunkel LM: Dystrophinopathies. In Neuromuscular Disorders of Infancy, Childhood and Adolescence-A Clinician’s Approach. Edited by: Jones HR, DeVivo DC, Darras BT. Butterworth Heinemann, Amsterdam; 2003:649–700.Google Scholar
- Hoffman EP: Dystrophinopathies. In Disorders of Muscle. Karpati G, Hilton-Jones D, Griggs RC edition. Cambridge University Press, Cambridge; 2001:385–482.Google Scholar
- Witte RA: The psychosocial impact of a progressive physical handicap and terminal illness (Duchenne muscular dystrophy) on adolescents and their families. Br J Med Psychol 1985, 58: 179–187. 10.1111/j.2044-8341.1985.tb02632.xView ArticleGoogle Scholar
- Gagliardi BA: The impact of Duchenne muscular dystrophy on families. Orthop Nurs 1991, 10(5):41–49. 10.1097/00006416-199109000-00009View ArticleGoogle Scholar
- Grootenhuis MA, de Boone J, van der Kooi AJ: Living with muscular dystrophy: health related quality of life consequences for children and adults. Health and Quality of Life Outcomes 2007, 5(31):1–8.Google Scholar
- Baiardini I, Minetti C, Bonifacino S, Porcu A, Klersy C, Petralia P, Balestracci S, Tarchino F, Parodi S, Canonica GW, Braido F: Quality of life in Duchenne muscular dystrophy: The subjective impact on children and parents. J Child Neurol 2011, 26(6):707–713. 10.1177/0883073810389043View ArticleGoogle Scholar
- Bray P: Thank, Ryan MM, North KN, Everett A: Health-related quality of life in boys with Duchenne muscular dystrophy: Agreement between parents and their sons. J Child Neurol 2010, 25(10):1188–1194. 10.1177/0883073809357624View ArticleGoogle Scholar
- Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ: Clinical trials in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981, 4: 186–197. 10.1002/mus.880040304View ArticleGoogle Scholar
- Scott OM, Hyde SA, Goddard C, Dubowitz V: Quantification of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 1982, 5: 291–301. 10.1002/mus.880050405View ArticleGoogle Scholar
- McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Elfring GL, Atkinson L, Reha A, Hirawat S, Miller LL: The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010, 41(4):500–510. 10.1002/mus.21544View ArticleGoogle Scholar
- Beenakker EA, Maurits NM, Fock JM, Brouwer OF, van der Hoeven JH: Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients. Eur J Paediatr Neurol 2005, 9: 387–393. 10.1016/j.ejpn.2005.06.004View ArticleGoogle Scholar
- Cossu G, Sampaolesi M: New therapies for Duchenne muscular dystrophy: Challenges, prospects and clinical trials. Trends Mol Med 2007, 13(12):520–526. 10.1016/j.molmed.2007.10.003View ArticleGoogle Scholar
- Chamberlain J, Rando T: Duchenne Muscular Dystrophy: Advances in Therapeutics. Taylor & Francis Group, New York; 2006.Google Scholar
- McDonald CM, Abresch RT, Carter GT, Fowler WM, Johnson ER, Kilmer DD, Sigford BJ: Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 1995, 74(5 Suppl):S70-S92.View ArticleGoogle Scholar
- Scott E, Mawson SJ: Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool. Dev Med Child Neurol 2006, 48: 540–544. 10.1017/S0012162206001137View ArticleGoogle Scholar
- Lollar DJ, Simeonsson RJ: Diagnosis to function: classification for children and youths. J Dev Behav Pediatr 2005, 26(4):323–330. 10.1097/00004703-200508000-00012View ArticleGoogle Scholar
- Keysor JJ, Jette AM, Coster W, Bettger JP, Haley SM: Association of environmental factors with levels of home and community participation in an adult rehabilitation cohort. Arch Phys Med Rehabil 2006, 87(12):1566–1575. 10.1016/j.apmr.2006.08.347View ArticleGoogle Scholar
- Jette AM, Keysor J, Coster W, Ni P, Haley S: Beyond function: predicting participation in a rehabilitation cohort. Arch Phys Med Rehabil 2005, 86(11):2087–2094. 10.1016/j.apmr.2005.08.001View ArticleGoogle Scholar
- World Health Organization (WHO): International Classification of Functioning, Disability and Health: Children & Youth Version. Geneva, Switzerland; 2007.Google Scholar
- World Health Organization (WHO): International Classification of Functioning, Disability and Health. Geneva, Switzerland; 2001.Google Scholar
- Law M, King G, King S, Kertoy M, Hurley P, Rosenbaum P, Young N, Hanna S: Patterns of participation in recreational and leisure activities among children with complex physical disabilities. Dev Med Child Neurol 2006, 48: 337–342. 10.1017/S0012162206000740View ArticleGoogle Scholar
- King G, Law M, King S, Hurley P, Hanna S, Kertoy P, Rosenbaum P: Measuring children’s participation in recreation and leisure activities: Construct validation of the CAPE and PAC. Child Care Health Dev 2006, 33(1):28–39.View ArticleGoogle Scholar
- Meijer SA, Sinnema G, Bijstra JO, Mellenbergh GJ, Wolters WH: Social functioning in children with a chronic illness. J Child Psychol Psychiatry 2000, 41(3):309–317. 10.1111/1469-7610.00615View ArticleGoogle Scholar
- Brown M, Gordon W: Impact of impairment on activity patterns of children. Arch Phys Med Rehabil 1987, 68: 828–832.Google Scholar
- Hollingsworth H, Morgan K, Cuthbert J, Grey D: Measure of quality of participation in life situations for people with mobility limitations. ICF Sessions at APHA Annual Meeting, San Francisco; 2003.Google Scholar
- Angelini C: The role of corticosteroids in muscular dystrophy: A critical appraisal. Muscle Nerve 2007, 36: 424–435. 10.1002/mus.20812View ArticleGoogle Scholar
- Eiser C, Morse R: The measurement of quality of life in children: past and future perspectives. J Dev Behav Pediatr 2001, 22: 248–256. 10.1097/00004703-200108000-00007View ArticleGoogle Scholar
- Zebracki K, Drotar D: Pain and activity limitations in children with Duchenne or Becker muscular dystrophy. Dev Med Child Neurol 2008, 50(7):546–552. 10.1111/j.1469-8749.2008.03005.xView ArticleGoogle Scholar
- Natterlund B, Ahlstrom G: Activities of daily living and quality of life in persons with muscular dystrophy. J Rehabil Med 2001, 33: 206–211. 10.1080/165019701750419590View ArticleGoogle Scholar
- Varni JW, Limbers CA, Burwinkle TM: Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core Scales. Health Qual Life Outcomes 2007, 5: 43. 10.1186/1477-7525-5-43PubMed CentralView ArticleGoogle Scholar
- Varni JW, Seid M, Kurtin PS: PedsQL™ 4.0: Reliability and validity of the pediatric quality of life inventory™ version 4.0 generic core scales in healthy and patient populations. Med Care 2001, 39(8):800–812. 10.1097/00005650-200108000-00006View ArticleGoogle Scholar
- Webb C: Parents's perspectives on coping with Duchene muscular dystrophy. Child Care Health Dev 2005, 31: 385–396. 10.1111/j.1365-2214.2005.00518.xView ArticleGoogle Scholar
- Bothwell JE, Dooley JM, Gordon KE, MacAuley A, Camfield PR, MacSween J: Duchenne muscular dystrophy—Parental perceptions. Clin Pediatr 2002, 41: 105–109. 10.1177/000992280204100206View ArticleGoogle Scholar
- King G, Law M, King S, Hurley P, Rosenbaum P, Hanna S, Kertoy M, Young N: Children’s Assessment of Participation and Enjoyment & Preferences for Activities of Children. Harcourt Assessment, Inc, San Antonio, TX; 2004.Google Scholar
- Eiser C, Morse R: A review of measures of quality of life for children with chronic illness. Arch Dis Child 2001, 84: 205–211. 10.1136/adc.84.3.205PubMed CentralView ArticleGoogle Scholar
- Clark S-A, Eiser C: The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review. Health Qual Life Outcomes 2004, 2: 66–70. 10.1186/1477-7525-2-66View ArticleGoogle Scholar
- Kohler M, Clarenbach F, Boni L, Brack T, Russi E, Bloch K: Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2005, 172: 1032–1036. 10.1164/rccm.200503-322OCView ArticleGoogle Scholar
- McDonald CM, McDonald DA, Bagley A, Thomas SS, Buckon CE, Henricson E, Nicorici A, Sussman MD: Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy. J Child Neurol 2010, 25(9):1130–1144. 10.1177/0883073810371509PubMed CentralView ArticleGoogle Scholar
- Moxley RT, Pandya S, Ciafaloni E, Fox DJ, Campbell K: Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol 2010, 25(9):1116–1129. 10.1177/0883073810371004View ArticleGoogle Scholar
- McDonald CM: Physical activity, health impairments, and disability in neuromuscular disease. Am J Phy Med Rehabil 2002, 81(Suppl 11):108–120.View ArticleGoogle Scholar
- McDonald CM, Widman LM, Walsh DD, Walsh SA, Abresch RT: Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2005, 86: 802–808. 10.1016/j.apmr.2004.10.012View ArticleGoogle Scholar
- Wall MI, Carlson SA, Stein AD, Lee SM, Fulton JE: Trends by age in youth physical activity: Youth media campaign longitudinal survey. Med Sci Sports Exerc 2011, 43: 2140–2147. Epub ahead of print 10.1249/MSS.0b013e31821f561aView ArticleGoogle Scholar
- Riddoch CH: Bo Andersen L, Wedderkopp N, Harro M, Klasson-Heggebǿ L, Sardinha LB, Cooper AR, Ekelund U: Physical activity levels and patterns of 9- and 15-year-old European children. Med Sci Sports Exerc 2004, 36: 86–92. 10.1249/01.MSS.0000106174.43932.92View ArticleGoogle Scholar
- Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M: Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 2008, 40: 181–188.View ArticleGoogle Scholar
- Livesey D: Lum Mow M, Toshack T, Zheng Y: The relationship between motor performance and peer relations in 9- to 12-year-old children. Child Care Health Dev 2010, 37(4):581–588.View ArticleGoogle Scholar
- Kinney VB, Coyle CP: Predicting life satisfaction among adults with physical disabilities. Arch Phys Med Rehabil 1992, 73: 863–869.Google Scholar
- Boyer F, Drame M, Morrone I, Novella J-L: Factors relating to carer burden for families of persons with muscular dystrophy. J Rehabil Med 2006, 38: 309–315. 10.1080/16501970600731578View ArticleGoogle Scholar
- Hinton V, Nereo N, Fee R, Cyrulnik S: Social behavior problems in boys with Duchenne musuclar dystrophy. Dev Behav Pediatr 2007, 27: 470–476.View ArticleGoogle Scholar
- Simon VA, Resende MB, Simon MA, Zanoteli E, Reed UC: Duchenne muscular dystrophy: Quality of life among 95 patients evaluated using the Life Satisfaction Index for Adolescents. Arq Neuropsiquiatr 2011, 69(1):19–22. 10.1590/S0004-282X2011000100005View ArticleGoogle Scholar
- Abresch RT, Carter GT, Han JJ, McDonald CM: New clinical end points in rehabilitation medicine: tools for measuring quality of life. Am J Hosp Palliat Care 2009, 26(6):483–492. 10.1177/1049909109352656View ArticleGoogle Scholar
- Abresch RT, Seyden NK, Wineinger MA: Quality of life. Issues for persons with neuromuscular diseases. Phys Med Rehabil Clin N Am 1998, 9(1):233–248.Google Scholar
- Huang I-C, Thompson LA, Chi Y-Y, Knapp CA, Revicki DA, Seid M, Shenkman EA: The linkage between pediatric quality of life and health conditions: Establishing clinically meaningful cutoff scores for the PedsQL. Value in Health 2009, 12(5):773–781. 10.1111/j.1524-4733.2008.00487.xPubMed CentralView ArticleGoogle Scholar
- Dijkers M, Whiteneck G: El-Jaroudi: Measures of social outcomes in disability research. Arch Phys Med Rehabil 2000, 81(Suppl 2):63–80.View ArticleGoogle Scholar
- Colver A: Quality of life and participation. Dev Med & Child Neuro 2009, 51: 656–659. 10.1111/j.1469-8749.2009.03321.xView ArticleGoogle Scholar
- Forsyth R, Jarvis S: Participation in childhood. Child Care Health Dev 2002, 28: 277–279. 10.1046/j.1365-2214.2002.00272.xView ArticleGoogle Scholar
- Heah T, Case T, McGuire B, Law M: Successful participation: the lived experience among children with disabilities. Can J Occup Ther 2007, 74: 38–47. 10.2182/cjot.06.10View ArticleGoogle Scholar
- Varni JW: The PedsQL™. Measurement model for the pediatric quality of life inventory. Medical Care 1999, 37(2):126–139. 10.1097/00005650-199902000-00003View ArticleGoogle Scholar
- Waters E, Stewart-Brown S, Fitzpatrick R: Agreement between adolescent self-report and parent reports of health and wellbeing: results of an epidemiological study. Child Care Health Dev 2003, 29: 501–509. 10.1046/j.1365-2214.2003.00370.xView ArticleGoogle Scholar
- Riley A: Evidence that school-age children can self-report on their health. Ambul Pediatr 2004, 4: 371–376. 10.1367/A03-178R.1View ArticleGoogle Scholar
- Rebok G, Riley AW, Forrest C, Starfield B, Green B, Robertson J, Tambor E: Elementary school-aged children’s reports of their health: a cognitive interviewing study. Qual Life Res 2001, 10: 59–70. 10.1023/A:1016693417166View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.